Dosage for Humira (adalimumab) may vary based on the condition it’s being used to treat. Also, your doctor may adjust your dosage over the course of your treatment. Be sure to take the Humira dosage ...
63% of surveyed gastroenterologists in the USA say they are prescribing Abbott/Eisai’s blockbuster arthritis treatment Humira (adalimumab) off-label for the treatment of ulcerative colitis, according ...
MONTREAL, Oct. 15, 2018 /CNW/ - AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that Health Canada has approved a label update for HUMIRA® (adalimumab) to ...
MONTREAL, Oct. 25, 2017 /CNW/ - AbbVie (NYSE: ABBV), a global biopharmaceutical company, today announced that Health Canada has approved the inclusion of nail psoriasis data in the HUMIRA Product ...
Abbott Labs ( ABT) recently received approval for yet another indication of Humira (adalimumab). The European Commission approved Humira for the treatment of severe active Crohn's disease (CD) in ...
The safety and efficacy of Humira in patients with moderate to severe fingernail psoriasis and moderate to severe chronic plaque psoriasis was evaluated in a Phase 3, multicenter, double-blind, ...
Patients with ankylosing spondylitis gain a significant therapeutic benefit from treatment with Abbott Laboratories’ Humira for at least a year, according to new data from the ATLAS study. Patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results